NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.3600
0.00 (0.00%)
Jul 23, 2025, 9:30 AM EDT
NexgenRx Revenue
NexgenRx had revenue of 4.55M CAD in the quarter ending March 31, 2025, with 8.14% growth. This brings the company's revenue in the last twelve months to 16.82M, up 15.22% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.
Revenue (ttm)
16.82M
Revenue Growth
+15.22%
P/S Ratio
1.44
Revenue / Employee
840.89K
Employees
20
Market Cap
24.18M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.58B |
| Curaleaf Holdings | 1.89B |
| WELL Health Technologies | 990.34M |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| Extendicare | 1.47B |
NexgenRx News
- 2 months ago - NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA - Accesswire
- 3 months ago - NexgenRx (NXG) Maintains Quarterly Dividend - GuruFocus
- 3 months ago - NexgenRx declares CAD 0.005 dividend - Seeking Alpha
- 3 months ago - NexgenRx Announces Declaration of Divdend - Accesswire
- 3 months ago - Nexgenrx reports FY results - Seeking Alpha
- 4 months ago - NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA - Accesswire
- 8 months ago - NexgenRx Announces Third Quarter Results and Declaration of Divdend - Accesswire
- 10 months ago - NexgenRX Announces Director Re-Appointment - Accesswire